Quarterly report [Sections 13 or 15(d)]

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.25.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock
January 2025 Registered Direct Offering [Member]
Common Stock
March 2025 Registered Direct Offering [Member]
Common Stock
Additional Paid-In Capital
January 2025 Registered Direct Offering [Member]
Additional Paid-In Capital
March 2025 Registered Direct Offering [Member]
Additional Paid-In Capital
Accumulated Deficit
January 2025 Registered Direct Offering [Member]
March 2025 Registered Direct Offering [Member]
At the Market Offering
Total
Balance at beginning at Dec. 31, 2023     $ 14,468     $ 57,871,070 $ (53,218,853)       $ 4,666,685
Balance at beginning, Common shares (in shares) at Dec. 31, 2023     14,468,229                
Share-Based Compensation           894,523         894,523
Share-Based Payments to Vendors     $ 90     305,510         305,600
Share-Based Payments to Vendors (in shares)     90,000                
Issuance of shares of common stock     $ 1,140     4,298,334         4,299,474
Issuance of shares of common stock (in shares)     1,139,662             1,121,793  
Warrant Exercise     $ 59     210,140         210,199
Warrant Exercise (in shares)     59,211                
Net Income (Loss)             (4,377,889)       (4,377,889)
Balance at ending at Mar. 31, 2024     $ 15,757     63,579,577 (57,596,742)       5,998,592
Balance at ending, Common shares (in shares) at Mar. 31, 2024     15,757,102                
Balance at beginning at Dec. 31, 2024     $ 17,031     67,920,046 (67,321,956)       $ 615,121
Balance at beginning, Common shares (in shares) at Dec. 31, 2024     17,030,686               17,030,686
Share-Based Compensation           333,598         $ 333,598
Share based compensation to settle accrued compensation           413,120         413,120
Share-Based Payments to Vendors     $ 159     109,921         $ 110,080
Share-Based Payments to Vendors (in shares)     158,767                
Issuance of shares of common stock $ 2,463 $ 2,150   $ 2,096,790 $ 887,270     $ 2,099,253 $ 889,420    
Issuance of shares of common stock (in shares) 2,463,058 2,150,000                  
Warrant Exercise (in shares)                     595,000
Pre-funded Warrant Exercise     $ 595     (595)          
Pre-funded Warrant Exercise (in shares)     595,000                
Net Income (Loss)             (2,149,193)       $ (2,149,193)
Balance at ending at Mar. 31, 2025     $ 22,398     $ 71,760,150 $ (69,471,149)       $ 2,311,399
Balance at ending, Common shares (in shares) at Mar. 31, 2025     22,397,511               22,397,511